Suppr超能文献

理解β-内酰胺类药物增强万古霉素肾毒性的机制:共生关系、近端肾小管线粒体代谢和β-内酰胺化学的综合分析。

Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam chemistry.

机构信息

Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA; Nestlé Health Science, Bridgewater Township, NJ, USA.

Division of Infectious Diseases, School of Medicine, Wayne State University, Detroit, MI, USA; Department of Pharmacy, Detroit Receiving Hospital, Detroit, MI, USA.

出版信息

Lancet Infect Dis. 2024 Mar;24(3):e179-e188. doi: 10.1016/S1473-3099(23)00432-2. Epub 2023 Oct 23.

Abstract

The recent understanding that hydrophobic β-lactams have greater affinity for organic anion transporter-3 (OAT-3) of the proximal renal tubule could provide valuable insights for anticipating β-lactams that may exacerbate vancomycin-induced nephrotoxicity. Vancomycin alone provides oxidative stress on the highly metabolic proximal tubular cells. Hydrophobic β-lactams (eg, piperacillin and anti-staphylococcal β-lactams) could have greater OAT-3 mediated uptake into proximal tubular cells than hydrophilic β-lactams (eg, most cephalosporins and carbapenems), thereby causing greater mitochondrial stress on these susceptible cells. It remains to be seen whether concomitant drugs that inhibit OAT-3 mediated cellular uptake of β-lactams into proximal tubular cells or provide antioxidant effects might mitigate β-lactam augmented vancomycin nephrotoxicity. Furthermore, the serum creatinine rise seen with vancomycin and hydrophobic β-lactams might represent competition for creatinine-secreting transporters (of which OAT-3 is one), thus, indicating creatinine retention rather than renal injury. In the meantime, clinicians are advised to utilise less nephrotoxic combinations in both empirical and directed antibiotic selection settings until further research is conducted.

摘要

最近的研究发现疏水性β-内酰胺类药物与近端肾小管的有机阴离子转运蛋白 3(OAT-3)具有更高的亲和力,这为预测可能加剧万古霉素肾毒性的β-内酰胺类药物提供了有价值的见解。万古霉素本身会对代谢活跃的近端肾小管细胞造成氧化应激。疏水性β-内酰胺类药物(如哌拉西林和抗葡萄球菌β-内酰胺类药物)比亲水性β-内酰胺类药物(如大多数头孢菌素类和碳青霉烯类药物)更容易通过 OAT-3 介导摄取进入近端肾小管细胞,从而对这些易受影响的细胞造成更大的线粒体应激。目前尚不清楚同时使用抑制β-内酰胺类药物进入近端肾小管细胞的 OAT-3 介导摄取的药物或提供抗氧化作用的药物是否可以减轻β-内酰胺类药物增强的万古霉素肾毒性。此外,万古霉素和疏水性β-内酰胺类药物引起的血清肌酐升高可能代表对肌酐分泌转运蛋白(其中 OAT-3 是一种)的竞争,因此表明肌酐潴留而不是肾损伤。在此期间,建议临床医生在进行进一步研究之前,在经验性和靶向抗生素选择中使用较少的肾毒性组合。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验